Thanks cj very useful from conservative to moderate looks good. Gee over 30 pages of posts just in march.
Printable View
Thanks cj very useful from conservative to moderate looks good. Gee over 30 pages of posts just in march.
Something to think about:
BiocancellTherapeutics Ltd., founded in 2004 by Avraham Hochberg, Professor of Molecular Biology at the Hebrew University of Jerusalem, reported success on Sunday in the treatment of bladder cancer using their lead product, BC-819. BC-819 is being tested on other cancers, such as, pancreatic cancer, superficial bladder carcinoma and ovarian cancer. Meanwhile, Protalix Biotherapeutics Inc., an Israeli company established in 1993 that recently developed the pioneering drug, Elelyso (Uplyso in Latin America), for treatment of the very rare Gaucher disease, announced on Monday that Brazil has approved the use of the drug. "The approval of Uplyso provides an important treatment option for those in Brazil using enzyme replacement therapy to manage their Gaucher disease and demonstrates the potential of our plant cell manufacturing technology," said Protalix CEO Dr. David Aviezer.
These appear to be two outfits that PEB should be talking to. PEB will find it - they can fix it - PEB can keep checking to make sure they have. WOW
Buyers now at 70 (albeit not many). The big seller hasn't swooped in with another lot of 100k, so maybe he's finished up? Time will tell.
Good buying interest at 70 cents and seller is now backing off.
Would say that we will see some more crossings at 70 cents and then, it's back to 75 cents.
Does not really matter in the end - it's what PEB's sp will be in 2 years' time which really matters.
SO treat the seller now at 70 cents as an opportunity to consider.
Definitely looks to me like one of the sellers at 70 cents is gone but there is one left.
Remember that PEB is now taking its story to not only urologists but investors as well.
The fact that the presentations were done at First NZ Capital office last week is an excellent sign. FNZC started covering Diligent at around the same price levels and actively got investors into Diligent.
Looks like it.
There's obviously two of them. One pulled his offer higher to 72 cents this morning when he saw that he was the lone seller at 70 cents but the other has re-entered the fray.
Oh well, let's see what happens when a volume buyer emerges on the scene. Can't be too far off as PEB takes its story to the States.